HI homepage

Hologic issues safety alert for breast biopsy needles

The safety notice was issued due to the risk of pieces of the needles dislodging into tissue during procedures. 

70cm bore Magnetom Flow platform
Siemens Healthineers' latest 'helium-free' MRI nabs FDA clearance

The health tech company announced the news Thursday, noting that the platform should help facilities address the growing demand for imaging.

Thumbnail
Radiology leader out $1M after online romance turns into crypto investment scam

A radiology manager from Connecticut is speaking out about being scammed by an individual she says took advantage of her emotions at a vulnerable time. 

Sarah-Jane James, CT, MRI, molecular imaging senior market analyst for Signify Research, explains key trends in imaging systems she saw at the Radiological Society of North America (RSNA) 2025 meeting.
Key trends in medical imaging systems at RSNA 2025

Sarah-Jane James, imaging market analyst for Signify Research, discusses key trends in the specialty that she saw at the Radiological Society of North America's annual meeting. 

burnout stress work staffing
Imaging volumes continue rising, but not all radiologists shouldering the same burden

The top 25% of busiest radiologists have read about 31% more studies since 2018 and work nearly 20% more clinical shifts per quarter, compared to seven years ago.

 

Aidoc Jesse M. Ehrenfeld
Radiology vendor Aidoc hires former AMA president as chief medical officer

A practicing anesthesiologist and clinical informaticist, Jesse M. Ehrenfeld, MD, MPH, will aid hospital systems in adopting AI tools from the New York-based technology firm. 

Around the web

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.